Please note that the posts on The Blogs are contributed by third parties. The opinions, facts and any media content in them are presented solely by the authors, and neither The Times of Israel nor its ...

Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.85, moving -3.27% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.33%. On ...

Amazon plans to close its Fresh supermarkets and Go convenience marts, and convert some locations into Whole Foods stores. It marks the latest pivot in Amazon's nearly two-decade effort to grab a ...

Artificial intelligence is moving beyond standalone large language model wrappers toward collections of specialized AI agents that reason, act, and collaborate to achieve complex outcomes. This ...

Ricursive Intelligence, a startup building an AI system to design and automatically improve AI chips, has raised $300 million at a $4 billion valuation. The company said Monday the round was led by ...

Apple is teaming up with Google to use Gemini models for an AI-powered Siri. Reports swirled in August that Apple was in early talks with the search giant to use a custom Gemini model to power a new ...

Who we are is not something that needs to be fixed. Yet for thousands of gay, lesbian, bisexual, and transgender young people across the U.S., conversion therapy continues to send the dangerous ...

According to @godofprompt, recursive prompting is an AI technique where system outputs are fed back in as inputs to refine solutions through multiple iterations (source: @godofprompt, Dec 16, 2025).

During her speech at Northwestern Engineering’s Fall 2025 PhD Hooding and Master’s Recognition Ceremony held Dec. 13 at Pick-Staiger Concert Hall, Christine Schyvinck (MEM ’99) told graduates that ...

In the early 2000s, Star Trek was all but dead. 2002's Star Trek: Nemesis had killed the franchise on the big screen and almost took the legacy of Star Trek: The Next Generation with it, until Star ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...